---
figid: PMC7541012__CAS-111-3468-g002
figlink: pmc/articles/PMC7541012/figure/cas14578-fig-0002/
number: F2
caption: Roles of cancer‐associated fibroblasts (CAFs) in cancer chemoresistance.
  CAFs affect anticancer resistance through various mechanisms, including secreted
  factors (red), the promotion of cancer stemness (orange), metabolic modulations
  (blue), and interference with immunotherapy (green). Upon stimulation with factors
  such as annexin A6, WNT16B, IL‐6, IL‐1β, IL‐8, and HGF, chemoresistance is enhanced
  via downstream pathways, including the STAT3, FAK‐YAP, NF‐κB and PI3K/p‐AKT signaling
  pathways. Stemness is increased by activation of ERK1/2, upregulation of GLI2, induction
  of IL‐6 and/or IL‐8 secretion from CD10+GPR77+ CAFs and activation of the SHH pathway.
  WNT5a also induces CAFs to produce stem cell niche factors. Furthermore, Ras signaling
  is facilitated by glutamine from CAFs through macropinocytosis, GFPT2 and HGF from
  CAFs reprograming cancer cells to engage in glycolysis, and GPER from cancer cells
  induced CAFs to produce lactate transporters that support cancer metabolism; all
  these activities eventually lead to drug resistance. Finally, CAFs polarize macrophages
  into the M2 phenotype, which suppress T cell activity. At the same time, CAFs secrete
  TGF‐β, PGE2, and IDO to alter the functions of NK cells and T cells
pmcid: PMC7541012
papertitle: Functional diversity of cancer‐associated fibroblasts in modulating drug
  resistance.
reftext: Luke Bu, et al. Cancer Sci. 2020 Oct;111(10):3468-3477.
pmc_ranked_result_index: '1783'
pathway_score: 0.9665341
filename: CAS-111-3468-g002.jpg
figtitle: Roles of cancer‐associated fibroblasts (CAFs) in cancer chemoresistance
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7541012__CAS-111-3468-g002.html
  '@type': Dataset
  description: Roles of cancer‐associated fibroblasts (CAFs) in cancer chemoresistance.
    CAFs affect anticancer resistance through various mechanisms, including secreted
    factors (red), the promotion of cancer stemness (orange), metabolic modulations
    (blue), and interference with immunotherapy (green). Upon stimulation with factors
    such as annexin A6, WNT16B, IL‐6, IL‐1β, IL‐8, and HGF, chemoresistance is enhanced
    via downstream pathways, including the STAT3, FAK‐YAP, NF‐κB and PI3K/p‐AKT signaling
    pathways. Stemness is increased by activation of ERK1/2, upregulation of GLI2,
    induction of IL‐6 and/or IL‐8 secretion from CD10+GPR77+ CAFs and activation of
    the SHH pathway. WNT5a also induces CAFs to produce stem cell niche factors. Furthermore,
    Ras signaling is facilitated by glutamine from CAFs through macropinocytosis,
    GFPT2 and HGF from CAFs reprograming cancer cells to engage in glycolysis, and
    GPER from cancer cells induced CAFs to produce lactate transporters that support
    cancer metabolism; all these activities eventually lead to drug resistance. Finally,
    CAFs polarize macrophages into the M2 phenotype, which suppress T cell activity.
    At the same time, CAFs secrete TGF‐β, PGE2, and IDO to alter the functions of
    NK cells and T cells
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LRP6
  - MAPK3
  - STAT3
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - FZD5
  - FZD7
  - FZD9
  - FZD2
  - FZD3
  - FZD1
  - FZD4
  - FZD6
  - FZD8
  - FZD10
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - IL6
  - IRAK4
  - CXCL8
  - HGF
  - IL18
  - LIF
  - IGF1
  - WNT5A
  - CHI3L1
  - GFPT2
  - GPER1
  - TGFB1
  - TGFB2
  - TGFB3
  - IL10
  - CLU
  - AKR1C4
  - C2
  - TCL1A
  - TCN2
  - IL17A
  - gemcitabine
  - cisplatin
  - CAF
  - Lactate
  - Glutamine
  - PGE2
  - cancer stemness
  - cancer
genes:
- word: LRP6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: ERK1/21
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: STAT3/NF-KB
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT3/NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: STAT3/NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: STAT3/NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: STAT3/NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: STAT3/NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NF-KB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: STAT3/
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/PAKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IRAK4
  symbol: IRAK4
  source: hgnc_symbol
  hgnc_symbol: IRAK4
  entrez: '51135'
- word: IL8,HGF
  symbol: IL8
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: IL8,HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: LIF
  symbol: LIF
  source: hgnc_symbol
  hgnc_symbol: LIF
  entrez: '3976'
- word: IGF-1,
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: IL6,IL8
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL6,IL8
  symbol: IL8
  source: hgnc_prev_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: WNT5A
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Chi3L1
  symbol: CHI3L1
  source: hgnc_symbol
  hgnc_symbol: CHI3L1
  entrez: '1116'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: GFPT2
  symbol: GFPT2
  source: hgnc_symbol
  hgnc_symbol: GFPT2
  entrez: '9945'
- word: GPER
  symbol: GPER
  source: hgnc_prev_symbol
  hgnc_symbol: GPER1
  entrez: '2852'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: IL10,IDO,TGF-Bt
  symbol: IL10
  source: hgnc_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: cll
  symbol: CLI
  source: hgnc_prev_symbol
  hgnc_symbol: CLU
  entrez: '1191'
- word: cll
  symbol: C11
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1C4
  entrez: '1109'
- word: cll
  symbol: C2
  source: hgnc_symbol
  hgnc_symbol: C2
  entrez: '717'
- word: Tcll
  symbol: TCL1
  source: hgnc_alias_symbol
  hgnc_symbol: TCL1A
  entrez: '8115'
- word: Tcll
  symbol: TC2
  source: hgnc_alias_symbol
  hgnc_symbol: TCN2
  entrez: '6948'
- word: IL-17A
  symbol: IL-17A
  source: hgnc_alias_symbol
  hgnc_symbol: IL17A
  entrez: '3605'
- word: TGF-B2
  symbol: TGFB2
  source: hgnc_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
chemicals:
- word: gemcitabine
  source: MESH
  identifier: C056507
- word: cisplatin
  source: MESH
  identifier: D002945
- word: CAF
  source: MESH
  identifier: C035000
- word: Lactate
  source: MESH
  identifier: D019344
- word: Glutamine
  source: MESH
  identifier: C578860
- word: PGE2
  source: MESH
  identifier: D015232
diseases:
- word: cancer stemness
  source: MESH
  identifier: D009369
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC7541012__F2
redirect_from: /figures/PMC7541012__F2
figtype: Figure
---
